Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL3833384

EFLAPEGRASTIM
💊 Approved Drug
Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
💊 Approved Drug
No structure available
ChEMBL ↗

Basic Information

ChEMBL ID CHEMBL3833384
Name EFLAPEGRASTIM
Phase Approved
Structure Type SEQ
Therapeutic ✓ Yes

Known Names

Eflapegrastim Eflapegrastim-xnst HM-10460A HM10460A HNK-460 HNK460 Rolvedon SPI-2012 SPL-2012
0
Targets
0
Activities
0
Assay Types
0
PK Parameters
0
Publications
9
Known Names
5
Indications
1
Mechanisms

Drug Information

Molecule Type Protein
First Approval 2022
Availability Prescription
Chirality Single Enantiomer

Routes of Administration

Parenteral
USAN Stem ef-; -peg-; -stim
USAN Year 2016

Mechanism of Action

Mechanism Action Type Target Direct Efficacy
Granulocyte colony stimulating factor receptor agonist AGONIST Granulocyte colony-stimulating factor receptor ✓ ✓

Indications

Febrile Neutropenia Neoplasms Neutropenia Lymphoma Breast Neoplasms

ATC Classification

L03AA19
eflapegrastim
Level 1: ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
Level 2: IMMUNOSTIMULANTS

Data from ChEMBL 36 via Core Engine